Editor's Choice - Timing of Carotid Intervention in Symptomatic Carotid Artery Stenosis: A Systematic Review and

Andreia Coelho1, João Peixoto2, Armando Mansilha3

  • 1Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário do Porto, Portugal; Department of Surgery and Physiology, Faculdade Medicina da Universidade do Porto, Portugal.

Insights

Carotid endarterectomy (CEA) is safer than carotid artery stenting (CAS) within 7 days of symptom onset. Expedited CEA meets international guidelines, while optimal CAS timing remains undefined.

Area of Science:

  • Vascular Surgery
  • Interventional Neurology
  • Clinical Outcomes Research

Background:

  • Timely intervention for symptomatic carotid artery stenosis is crucial for stroke prevention.
  • Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are primary revascularization strategies.
  • Optimal timing for these procedures relative to symptom onset is debated.

Purpose of the Study:

  • To analyze the timing of CEA and CAS after symptom onset.
  • To evaluate 30-day outcomes for CEA and CAS at varying time intervals within 14 days.
  • To compare the safety and efficacy of CEA versus CAS based on procedural timing.

Main Methods:

  • Systematic review adhering to PRISMA guidelines.
  • Searched Medline and Cochrane databases for relevant studies.
  • Included 71 studies with 232,952 symptomatic patients; assessed study quality.
  • Endpoints included procedural stroke and/or death, stratified by delay and technique (CEA/CAS).

Main Results:

  • CAS showed higher 30-day stroke and mortality rates compared to CEA when performed within 2 days of symptom onset.
  • Expedited CEA (≤2 days) showed no significant difference in 30-day stroke rates versus later intervention (3-14 days).
  • Expedited CAS (≤2 days) had similar stroke rates but significantly higher mortality compared to later intervention (3-14 days).

Conclusions:

  • Carotid endarterectomy (CEA) is safer than transfemoral CAS within the first 7 days of symptom onset.
  • Expedited CEA aligns with international guidelines regarding absolute stroke rates.
  • The optimal timing for CAS, when indicated over CEA, requires further definition and standardized reporting.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
59
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
47
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
44
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
48
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
47